Sleep Deprivation May Increase Risk for Systemic Lupus in Women
Additive interactions between low sleep duration and depression or bodily pain may contribute to risk for systemic lupus erythematosus (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 22, 2022 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Neurology, Psychiatry, Rheumatology, Anesthesiology & amp; Pain, Journal, Source Type: news

Sleep Deprivation May Increase Risk for Systemic Lupus in Women
THURSDAY, Sept. 22, 2022 -- Lack of sleep is associated with an increased risk for systemic lupus erythematosus (SLE), particularly among women with concomitant depression or bodily pain, according to a study published online Sept. 12 in Arthritis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2022 Category: Pharmaceuticals Source Type: news

Cell-Killing Cancer Therapy Treats Lupus Successfully Cell-Killing Cancer Therapy Treats Lupus Successfully
' Our data reveal unexpected insights for a role of CAR T cells in nonmalignant diseases that could provide new opportunities for the treatment of autoimmune disease, ' the study authors write.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2022 Category: Cancer & Oncology Tags: Rheumatology News Source Type: news

The Disparity of Outcomes in Persons of Color Living With Systemic Lupus Erythematosus The Disparity of Outcomes in Persons of Color Living With Systemic Lupus Erythematosus
Michelle Petri, MD, discusses the more frequent and worse kidney outcomes in African American and Hispanic American individuals living with systemic lupus erythematosus (SLE).Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2022 Category: Consumer Health News Tags: Rheumatology MDAngle Source Type: news

Treatment of Systemic Lupus Erythematosus: An Appreciation of Mentorship Treatment of Systemic Lupus Erythematosus: An Appreciation of Mentorship
Michelle Petri, MD, recalls lessons learned from a respected mentor.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2022 Category: Consumer Health News Tags: Rheumatology MDAngle Source Type: news

In Small Study, CAR-T Therapy Pushes Lupus Into Remission
While there's no cure for lupus and treatments don't work for everyone with the disease, a new study shows a cancer therapy may kick hard-to-treat lupus into remission. (Source: WebMD Health)
Source: WebMD Health - September 15, 2022 Category: Consumer Health News Source Type: news

In Small Study, CAR-T Therapy Pushes Lupus Into Remission
THURSDAY, Sept. 15, 2022 -- While there’s no cure for lupus and treatments don’t work for many of the 1.5 million people who live with the disease in the United States, a new study shows a cancer therapy may kick hard-to-treat lupus into... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 15, 2022 Category: General Medicine Source Type: news

Cell-killing cancer therapy shows promise for a devastating autoimmune disorder
Opening a new frontier in fighting autoimmune disease, researchers have successfully treated five lupus patients with a novel cell therapy that turns run-of-the-mill immune cells into specialized hunters of rogue cells helping fuel illness. The patients treated with the new therapy all saw their severe symptoms, including kidney and other organ dysfunction, largely disappear. The results “are phenomenal,” says Betty Diamond, an immunologist and rheumatologist at the Feinstein Institutes for Medical Research who cares for lupus patients and was not involved in the work. Despite her excitement, she cautions that th...
Source: ScienceNOW - September 15, 2022 Category: Science Source Type: news

Scientists hail autoimmune disease therapy breakthrough
Study finds CAR T-cell treatment sends lupus into remission, raising hopes it could be used to treat diseases such multiple sclerosisFive people with severe autoimmune disease have become the first in the world to receive a groundbreaking therapy that uses genetically altered cells to drive the illness into remission.The four women and one man, aged 18 to 24, received transfusions of modified immune cells to treat severe lupus, an autoimmune disease that can cause life-threatening damage to the heart, lungs, brain and kidneys.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 15, 2022 Category: Science Authors: Ian Sample Science editor Tags: Science Health Genetics Multiple sclerosis Source Type: news

Is Cancer Therapy Also a Lupus Cure?
(MedPage Today) -- Autologous chimeric antigen receptor T-cell (CAR-T) therapy, an approach that has taken the oncology world by storm in recent years, could also revolutionize treatment for systemic lupus erythematosus (SLE), preliminary results... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 15, 2022 Category: Hematology Source Type: news

Lupus, Psoriasis Patients May Face Greater Dangers After Heart Attack
THURSDAY, Sept. 15, 2022 -- People with autoimmune disorders like lupus, rheumatoid arthritis or psoriasis who suffer a heart attack are more likely to die or develop severe heart-related complications in the aftermath, a new study shows. A heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 15, 2022 Category: General Medicine Source Type: news

Low Sleep Tied to Lupus Risk
(MedPage Today) -- Women's risk of new-onset systemic lupus erythematosus (SLE) was linked to habitually getting less-than-recommended sleep, according to Nurses Health Study (NHS) data, although an actual causal relationship remained uncertain... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 13, 2022 Category: Primary Care Source Type: news

Litifilimab Meets Primary Endpoint in Phase 2 Lupus Trial Litifilimab Meets Primary Endpoint in Phase 2 Lupus Trial
Treatment group saw greater reduction in number of tender and swollen joints.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 13, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

Novel Study Offers Clues to Sex Bias in Lupus Incidence Novel Study Offers Clues to Sex Bias in Lupus Incidence
Researchers compared immune cells in cisgender and transgender subjects to investigate the role of sex hormones independently from chromosomes in a study on sex bias in autoimmune disease.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 12, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

Reduction in Swollen, Tender Joints Greater With Litifilimab in Lupus
THURSDAY, Sept. 8, 2022 -- Patients with systemic lupus erythematosus (SLE) receiving litifilimab, a humanized monoclonal antibody that binds to blood dendritic cell antigen 2, versus placebo have a greater reduction in the number of swollen and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 8, 2022 Category: Pharmaceuticals Source Type: news